Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Living & Coping with ALS: Multidisciplinary Care, Adaptive Technologies, Respiratory & Nutritional Support, and Emotional Resilience

A chronic care guide on multidisciplinary ALS clinics, mobility and home adaptation, communication devices, non-invasive ventilation, feeding tubes, disease-modifying therapy, advance care planning and carepartner support.

Submitted research brief - Submitted to OwieClear; written with an AI assistant - November 2026

Read this first. This document was written outside OwieClear and has not been reviewed by a clinician. We publish it so you can read the source for yourself. It is educational and is not medical advice. Where our own pages disagree with it, follow our pages, which cite their sources, and ask a healthcare professional about anything that affects your care.

What we found that needs correcting

  • This guide is well built and its organizing idea is the right one: anticipating changes rather than reacting to them. The multidisciplinary clinic, ventilation, feeding tube and advance planning sections are all accurate. The notes below start with the one thing that has a closing window and cannot be done later.
  • Voice banking and message banking are missing, and they are the most time-critical items in ALS care after breathing. Voice banking records phrases from which a synthetic voice is built, so a communication device can later speak in something recognizably yours. Message banking records specific phrases in your actual voice, the things you say often and the way you say them. Both require speech that is still clear, modern systems need less recording than they used to, and several services are free or low cost. Done in the first weeks after diagnosis it takes a few hours. Left until speech has changed, the result is poorer, and eventually it is not possible at all. The guide covers speech-generating devices and eye tracking well and skips the step that makes them personal.
  • Cough assist is absent. A mechanical insufflation-exsufflation device clears secretions that weakened chest muscles cannot, and prevents the chest infections that are a common cause of deterioration. It belongs beside non-invasive ventilation, not after a crisis.
  • Secretion management more broadly deserves a place. Drooling from thin saliva is treated with anticholinergic medicines such as glycopyrrolate, atropine drops, or botulinum toxin injections into the salivary glands. Thick secretions respond to different measures including nebulized saline, humidification and the cough assist. Bedside suction is standard. Families frequently assume all of this is simply part of the disease.
  • On feeding tube timing, the guide says early placement and could be specific about why. Procedural risk rises as respiratory function falls, so placement is generally recommended before forced vital capacity drops below about 50 percent of predicted. Waiting until eating has become impossible often means waiting until the procedure is harder.
  • The disease-modifying therapy list needs updating. Riluzole and edaravone are correct. Tofersen should be added for SOD1-associated ALS, which is also the reason genetic testing is now offered broadly. And Relyvrio, which appears on many lists still in circulation, was withdrawn from the market in 2024 after its confirmatory phase 3 trial did not show benefit. A current guide should say so, because people are still asking for it.
  • Symptom management is thin. Treatable symptoms in ALS include cramps, spasticity, pain, constipation, sleep disturbance, anxiety and depression, and pseudobulbar affect, the uncontrollable laughing or crying that is distressing and specifically treatable. Each has an approach, and people endure them believing they are untreatable.
  • Benefits are missing and are unusually favourable in ALS, which few families know. In the United States ALS is on the Social Security Compassionate Allowances list; the five-month SSDI waiting period was eliminated for ALS in December 2020; and the 24-month Medicare waiting period was waived for ALS in 2000, so Medicare begins when SSDI does. Veterans with 90 days or more of continuous active service have ALS recognized as service-connected. A guide about living with ALS that omits this leaves money and coverage on the table during the months it is needed most.
  • Equipment timing deserves its own point. Funding approval and delivery for a powered wheelchair or home modification commonly takes months, so ordering starts well before the item is needed. Loan closets run by ALS organizations and the Muscular Dystrophy Association often supply equipment faster than insurance.
  • Palliative care should be named and placed early. It is symptom and quality-of-life care that runs alongside everything else, and evidence across serious illness shows it improves quality of life without shortening it. The guide's advance care planning section is good and would be stronger with this alongside it, including the tracheostomy decision, which is the largest in ALS and is far better discussed in advance than in an emergency department.
  • Two additions on safety and honesty. Manual handling injuries among family carers are common, and a hoist, a proper bed and training in transfers protect the carer as much as the person. And ALS attracts an unusual volume of unproven treatment, including stem cell clinics abroad and supplement protocols, which cost a great deal, carry real risk and have shown no benefit; the clinic is the cheapest second opinion available.
  • Everything else in the guide is accurate: proactive intervention as the organizing principle; multidisciplinary clinics reducing hospital visits and extending survival; wheelchairs, ramps, stairlifts and bathroom modifications for safe mobility and energy conservation; speech-generating devices, eye-tracking and text-to-speech preserving communication; non-invasive ventilation improving nocturnal oxygenation, fatigue, comfort and longevity; maintaining weight and PEG placement for safe nutrition and medication without aspiration risk; discussing riluzole and edaravone with a neurologist; peer support and specialized mental health care; advance directives, healthcare proxy and living wills established while fully able; and respite care, home health aides and support networks for carepartners.

Download the PDF

All source documents